US 11197821
Formulations for treatment of dry eye disease
granted A61KA61K31/47A61K47/40
Quick answer
US patent 11197821 (Formulations for treatment of dry eye disease) held by Aldeyra Therapeutics, Inc. expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/47, A61K47/40, A61K9/0048, A61K9/08